Spire Healthcare weighs strategic options amid shareholder pressure
Spire Healthcare’s board has confirmed it is “actively evaluating appropriate action that could drive long-term shareholder value,” appointing Rothschild & Co to examine avenues that include a potential sale of the UK’s second-largest private hospital operator. The announcement triggered an immediate market response: Spire shares jumped as much as 13 % to 245p, lifting the group’s market capitalisation to £872m before dropping.…